Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Isabelle von Glasenapp"'
Autor:
Bertrand Lell, Selidji Agnandji, Isabelle von Glasenapp, Sonja Haertle, Sunny Oyakhiromen, Saadou Issifou, Johan Vekemans, Amanda Leach, Marc Lievens, Marie-Claude Dubois, Marie-Ange Demoitie, Terrell Carter, Tonya Villafana, W Ripley Ballou, Joe Cohen, Peter G Kremsner
Publikováno v:
PLoS ONE, Vol 4, Iss 10, p e7611 (2009)
The malaria vaccine candidate antigen RTS,S includes parts of the pre-erythrocytic stage circumsporozoite protein fused to the Hepatitis B surface antigen. Two Adjuvant Systems are in development for this vaccine, an oil-in water emulsion--based form
Externí odkaz:
https://doaj.org/article/0b8ccbf0dd344497a95947dd36876a62
Autor:
Bertrand Lell, Claude Oeuvray, Sabine Bélard, Judith Kammer, Meike Schlie, Saadou Issifou, Benjamin Mordmüller, Florian Kurth, Lawrence Fleckenstein, Badara Cisse, Michael Ramharter, Johannes Nemeth, Isabelle von Glasenapp, Annette C. Schreier, Peter G. Kremsner, Philemon Koumba Koumba
Publikováno v:
The Journal of infectious diseases. 198(6)
The development of novel artemisinin-combination therapies suitable for the treatment of pediatric patients suffering from malaria is a research priority. The aim of this study was to investigate a novel fixed-dose pyronaridine-artesunate combination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e17dd4502b0012cb2920d12b914c89c
https://pubmed.ncbi.nlm.nih.gov/18694333
https://pubmed.ncbi.nlm.nih.gov/18694333
Autor:
Martin P. Grobusch, Peter G. Kremsner, Kai B. Köster, Jenny Dornemann, Peter Pongratz, Julian J. Gabor, Bertrand Lell, Georg Kiessling, Benjamin Naumann, Magdalena Necek, Julia Goesch, Christian Supan, Selidji T Agnandji, Isabelle von Glasenapp, Matthias Längin, Peter M. C. Klein Klouwenberg, Marie-Luise Decker, Davy U Kombila, Carmen L. Ospina Salazar, Lea B. Borchert, Norbert Georg Schwarz, A.A. Adegnika, Handan Altun, Saadou Issifou, Sunny Oyakhirome, Marc Pötschke, Anna Klöpfer
Publikováno v:
Journal of infectious diseases, 196(11), 1595-1602. Oxford University Press
BACKGROUND: Intermittent preventive treatment aims to maximize the protective effects of malaria chemoprophylaxis while minimizing the deleterious effects. METHODS: In Gabon, 1189 infants received either sulfadoxine-pyrimethamine (SP; 250 and 12.5 mg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29857fae59f20ca422c5ede667ebdfa9
https://pubmed.ncbi.nlm.nih.gov/18008242
https://pubmed.ncbi.nlm.nih.gov/18008242
Autor:
Sunny Oyakhiromen, Peter G. Kremsner, Marie-Claude Dubois, Sonja Haertle, Marie-Ange Demoitié, Amanda J. Leach, Joe Cohen, Tonya Villafana, Johan Vekemans, Selidji T Agnandji, Terrell Carter, Isabelle von Glasenapp, Marc Lievens, W. Ripley Ballou, Bertrand Lell, Saadou Issifou
Publikováno v:
PLoS ONE
PLoS ONE, Vol 4, Iss 10, p e7611 (2009)
PLoS ONE, Vol 4, Iss 10, p e7611 (2009)
Background: The malaria vaccine candidate antigen RTS,S includes parts of the pre-erythrocytic stage circumsporozoite protein fused to the Hepatitis B surface antigen. Two Adjuvant Systems are in development for this vaccine, an oil-in water emulsion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ddf68b089bfb126bcf136473e412762
https://doi.org/10.1371/journal.pone.0007611
https://doi.org/10.1371/journal.pone.0007611